Intrasense postpones the publication of its 2026 half-year results

On July 24, 2026, Intrasense, a company specializing in medical imaging solutions enhanced by artificial intelligence, announced the postponement of the publication of its half-year results, initially scheduled for September 15, 2026. The announcement will now take place after the close of financial markets on September 28, 2026. This delay is due to a change in schedule at Guerbet, its parent company.

This postponement is notable in the context of Intrasense's integration into Guerbet since 2023. Intrasense continues to develop its product ranges, including Myrian® and DUOnco™, which integrate AI algorithms for oncology applications.